|
參考文獻 1.Wu, S. H.; Yu, Z. H.; Dai, Y. C.; Chen, C. T.; Su, C. H.; Chen, L. C.; Hsu, W. C.; Hwang, G. Y., Taiwanofungus, a polypore new genus. Fungal Sci. 2004, 19, 109-116. 2.Cherng, I.-H.; Chiang, H.-C.; Cheng, M.-C.; Wang, Y., Three new triterpenoids from Antrodia cinnamomea. J. Nat. Prod. 1995, 58, 365-371. 3.Ao, Z. H.; Xu, Z. H.; Lu, Z. M.; Xu, H. Y.; Zhang, X. M.; Dou, W. F., Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J. Ethnopharmacol. 2009, 121, 194-212. 4.Liu, Y.; Lu, K.; Ho, C.; Sheen, L., Protective effects of Antrodia cinnamomea against liver injury. J. Tradit. Complemen. Med. 2012, 2, 284-294. 5.Lu, M. C.; El-Shazly, M.; Wu, T. Y.; Du, Y. C.; Chang, T. T.; Chen, C. F.; Hsu, Y. M.; Lai, K. H.; Chiu, C. P.; Chang, F. R.; Wu, Y. C., Recent research and development of Antrodia cinnamomea. Pharmacol. Ther. 2013, 139, 124-156. 6.Chiang, P. C.; Lin, S. C.; Pan, S. L.; Kuo, C. H.; Tsai, I. L.; Kuo, M. T.; Wen, W. C.; Chen, P.; Guh, J. H., Antroquinonol displays anticancer potential against human hepatocellular carcinoma cells: a crucial role of AMPK and mTOR pathways. Biochem. Pharmacol. 2010, 79, 162-171. 7.Lin, Y. W.; Pan, J. H.; Liu, R. H.; Kuo, Y. H.; Sheen, L. Y.; Chiang, B. H., The 4-acetylantroquinonol B isolated from mycelium of Antrodia cinnamomea inhibits proliferation of hepatoma cells. J. Sci. Food Agric. 2010, 90, 1739-1744. 8.Yu, C. C.; Chiang, P. C.; Lu, P. H.; Kuo, M. T.; Wen, W. C.; Chen, P.; Guh, J. H., Antroquinonol, a natural ubiquinone derivative, induces a cross talk between apoptosis, autophagy and senescence in human pancreatic carcinoma cells. J. Nutr. Biochem. 2012, 23, 900-907. 9.Yeh, C. T.; Rao, Y. K.; Yao, C. J.; Yeh, C. F.; Li, C. H.; Chuang, S. E.; Luong, J. H.; Lai, G. M.; Tzeng, Y. M., Cytotoxic triterpenes from Antrodia camphorata and their mode of action in HT-29 human colon cancer cells. Cancer Lett. 2009, 285, 73-79. 10.Chiou, J. F.; Wu, A. T.; Wang, W. T.; Kuo, T. H.; Gelovani, J. G.; Lin, I. H.; Wu, C. H.; Chiu, W. T.; Deng, W. P., A preclinical evaluation of Antrodia camphorata alcohol extracts in the treatment of non-small cell lung cancer using non-invasive molecular imaging. Evid. Based Complement. Alternat. Med. 2011, 2011, 1-12. 11.Hseu, Y. C.; Wu, F. Y.; Wu, J. J.; Chen, J. Y.; Chang, W. H.; Lu, F. J.; Lai, Y. C.; Yang, H. L., Anti-inflammatory potential of Antrodia Camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-kappaB pathway. Int. Immunopharmacol. 2005, 5, 1914-1925. 12.Yang, S. S.; Wang, G. J.; Wang, S. Y.; Lin, Y. Y.; Kuo, Y. H.; Lee, T. H., New constituents with iNOS inhibitory activity from mycelium of Antrodia camphorata. Planta Med. 2009, 75, 512-516. 13.Chen, C. C.; Liu, Y. W.; Ker, Y. B.; Wu, Y. Y.; Lai, E. Y.; Chyau, C. C.; Hseu, T. H.; Peng, R. Y., Chemical characterization and anti-inflammatory effect of polysaccharides fractionated from submerge-cultured Antrodia camphorata mycelia. J. Agric. Food Chem. 2007, 55, 5007-5012. 14.Hsieh, Y. H.; Chu, F. H.; Wang, Y. S.; Chien, S. C.; Chang, S. T.; Shaw, J. F.; Chen, C. Y.; Hsiao, W. W.; Kuo, Y. H.; Wang, S. Y., Antrocamphin A, an anti-inflammatory principal from the fruiting body of Taiwanofungus camphoratus, and its mechanisms. J. Agric. Food Chem. 2010, 58, 3153-3158. 15.Huang, C. H.; Chang, Y. Y.; Liu, C. W.; Kang, W. Y.; Lin, Y. L.; Chang, H. C.; Chen, Y. C., Fruiting body of Niuchangchih (Antrodia camphorata) protects livers against chronic alcohol consumption damage. J. Agric. Food Chem. 2010, 58, 3859-3866. 16.Huang, G.-J.; Deng, J.-S.; Huang, S.-S.; Shao, Y.-Y.; Chen, C.-C.; Kuo, Y.-H., Protective effect of antrosterol from Antrodia camphorata submerged whole broth against carbon tetrachloride-induced acute liver injury in mice. Food Chem. 2012, 132, 709-716. 17.Lai, M.-N.; Ko, H.-J.; Ng, L.-T., Hypolipidemic effects of Antrodia cinnamomea extracts in high-fat diet-fed hamsters. J. Food Biochem. 2012, 36, 233-239. 18.Suk, F. M.; Lin, S. Y.; Chen, C. H.; Yen, S. J.; Su, C. H.; Liu, D. Z.; Hou, W. C.; Hung, L. F.; Lin, P. J.; Liang, Y. C., Taiwanofungus camphoratus activates peroxisome proliferator-activated receptors and induces hypotriglyceride in hypercholesterolemic rats. Biosci. Biotechnol. Biochem. 2008, 72, 1704-1713. 19.Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106, 3143-3421. 20.Fuentes, R.; Uusitalo, T.; Puska, P.; Tuomilehto, J.; Nissinen, A., Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries: a review of population-based studies carried out from 1979 to 2002. Eur. J. Cardiovasc. Prev. Rehabil. 2003, 10, 411-419. 21.Assmann, G.; Cullen, P.; Jossa, F.; Lewis, B.; Mancini, M., Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 1819-1824. 22.Sharrett, A. R.; Ballantyne, C. M.; Coady, S. A.; Heiss, G.; Sorlie, P. D.; Catellier, D.; Patsch, W., Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circulation 2001, 104, 1108-1113. 23.Heinecke, J. W., Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998, 141, 1-15. 24.Van Gaal, L. F.; Mertens, I. L.; De Block, C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444, 875-880. 25.Glass, C. K.; Witztum, J. L., Atherosclerosis. the road ahead. Cell 2001, 104, 503-516. 26.Ross, R., Atherosclerosis--an inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126. 27.Gotto, A. M., Jr.; Pownall, H. J.; Havel, R. J., Introduction to the plasma lipoproteins. Methods Enzymol. 1986, 128, 3-41. 28.Ginsberg, H. N., Lipoprotein physiology and its relationship to atherogenesis. Endocrinol. Metab. Clin. North Am. 1990, 19, 211-228. 29.Havel, R. J.; Eder, H. A.; Bragdon, J. H., The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34, 1345-1353. 30.Green, P. H.; Glickman, R. M., Intestinal lipoprotein metabolism. J. Lipid Res. 1981, 22, 1153-1173. 31.Bisgaier, C. L.; Glickman, R. M., Intestinal synthesis, secretion, and transport of lipoproteins. Annu. Rev. Physiol. 1983, 45, 625-636. 32.Skottova, N.; Savonen, R.; Lookene, A.; Hultin, M.; Olivecrona, G., Lipoprotein lipase enhances removal of chylomicrons and chylomicron remnants by the perfused rat liver. J. Lipid Res. 1995, 36, 1334-1344. 33.Beisiegel, U.; Weber, W.; Bengtsson-Olivecrona, G., Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 8342-8346. 34.Chan, D. C.; Barrett, P. H.; Watts, G. F., Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies. Clin. Sci. (Lond.) 2004, 107, 221-232. 35.Demant, T.; Carlson, L. A.; Holmquist, L.; Karpe, F.; Nilsson-Ehle, P.; Packard, C. J.; Shepherd, J., Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J. Lipid Res. 1988, 29, 1603-1611. 36.Smith, J. R.; Osborne, T. F.; Goldstein, J. L.; Brown, M. S., Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J. Biol. Chem. 1990, 265, 2306-2310. 37.Smith, J. R.; Osborne, T. F.; Brown, M. S.; Goldstein, J. L.; Gil, G., Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J. Biol. Chem. 1988, 263, 18480-18487. 38.Horton, J. D., Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem. Soc. Trans. 2002, 30, 1091-1095. 39.Horton, J. D.; Goldstein, J. L.; Brown, M. S., SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109, 1125-1131. 40.Osborne, T. F., Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 2000, 275, 32379-32382. 41.Deng, Q.; Li, X.; Fu, S.; Yin, L.; Zhang, Y.; Wang, T.; Wang, J.; Liu, L.; Yuan, X.; Sun, G.; Wang, Z.; Liu, G.; Li, X., SREBP-1c gene silencing can decrease lipid deposits in bovine hepatocytes cultured in vitro. Cell. Physiol. Biochem. 2014, 33, 1568-1578. 42.Kim, Y. W.; Kim, Y. M.; Yang, Y. M.; Kim, T. H.; Hwang, S. J.; Lee, J. R.; Kim, S. C.; Kim, S. G., Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis. Free Radic. Biol. Med. 2010, 48, 567-578. 43.Oshaghi, E. A., Effects of walnut on lipid profile as well as the expression of sterol-regulatory element binding protein-1c (SREBP-1c) and peroxisome proliferator activated receptors α (PPARα) in diabetic rat. Food and Nutrition Sciences 2012, 3, 255-259. 44.Lane, M. D.; Hu, Z.; Cha, S. H.; Dai, Y.; Wolfgang, M.; Sidhaye, A., Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. Biochem. Soc. Trans. 2005, 33, 1063-1067. 45.Smith, A. C.; Cronan, J. E., Dimerization of the bacterial biotin carboxylase subunit is required for acetyl coenzyme A carboxylase activity in vivo. J. Bacteriol. 2012, 194, 72-78. 46.lHarwood, H. J., Jr.; Petras, S. F.; Shelly, L. D.; Zaccaro, L. M.; Perry, D. A.; Makowski, M. R.; Hargrove, D. M.; Martin, K. A.; Tracey, W. R.; Chapman, J. G.; Magee, W. P.; Dalvie, D. K.; Soliman, V. F.; Martin, W. H.; Mularski, C. J.; Eisenbeis, S. A., Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J. Biol. Chem. 2003, 278, 37099-37111. 47.Guo, P.; Kai, Q.; Gao, J.; Lian, Z.-q.; Wu, C.-m.; Wu, C.-a.; Zhu, H.-b., Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. J. Pharmacol. Sci. 2010, 113, 395-403. 48.Chakravarty, B.; Gu, Z.; Chirala, S. S.; Wakil, S. J.; Quiocho, F. A., Human fatty acid synthase: structure and substrate selectivity of the thioesterase domain. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 15567-15572. 49.Latasa, M. J.; Griffin, M. J.; Moon, Y. S.; Kang, C.; Sul, H. S., Occupancy and function of the -150 sterol regulatory element and -65 E-box in nutritional regulation of the fatty acid synthase gene in living animals. Mol. Cell. Biol. 2003, 23, 5896-5907. 50.Paulauskis, J. D.; Sul, H. S., Hormonal regulation of mouse fatty acid synthase gene transcription in liver. J. Biol. Chem. 1989, 264, 574-577. 51.Wang, Y.; Jones Voy, B.; Urs, S.; Kim, S.; Soltani-Bejnood, M.; Quigley, N.; Heo, Y. R.; Standridge, M.; Andersen, B.; Dhar, M.; Joshi, R.; Wortman, P.; Taylor, J. W.; Chun, J.; Leuze, M.; Claycombe, K.; Saxton, A. M.; Moustaid-Moussa, N., The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J. Nutr. 2004, 134, 1032-1038. 52.Gillespie, J. G.; Hardie, D. G., Phosphorylation and inactivation of HMG-CoA reductase at the AMP-activated protein kinase site in response to fructose treatment of isolated rat hepatocytes. FEBS Lett. 1992, 306, 59-62. 53.Van Rooyen, D. M.; Farrell, G. C., SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH. J. Gastroenterol. Hepatol. 2011, 26, 789-795. 54.Jung, J. H.; Kim, H. S., The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. Food Chem. Toxicol. 2013, 60, 404-412. 55.Ness, G. C.; Gertz, K. R., Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol. Exp. Biol. Med. (Maywood) 2004, 229, 412-416. 56.Lee, C. L.; Tsai, T. Y.; Wang, J. J.; Pan, T. M., In vivo hypolipidemic effects and safety of low dosage Monascus powder in a hamster model of hyperlipidemia. Appl. Microbiol. Biotechnol. 2006, 70, 533-540. 57.Lee, C. L.; Hung, H. K.; Wang, J. J.; Pan, T. M., Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. J. Agric. Food Chem. 2007, 55, 7162-7169. 58.Usifo, E.; Leigh, S. E.; Whittall, R. A.; Lench, N.; Taylor, A.; Yeats, C.; Orengo, C. A.; Martin, A. C.; Celli, J.; Humphries, S. E., Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann. Hum. Genet. 2012, 76, 387-401. 59.Brown, M. S.; Goldstein, J. L., Receptor-mediated endocytosis: insights from the lipoprotein receptor system. Proc. Natl. Acad. Sci. U. S. A. 1979, 76, 3330-3337. 60.Go, G. W.; Mani, A., Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J. Biol. Med. 2012, 85, 19-28. 61.Moon, M. S.; Lee, M. S.; Kim, C. T.; Kim, Y., Dietary chitosan enhances hepatic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats. Nutr. Res. Pract. 2007, 1, 175-179. 62.Chang, T.-Y.; Li, B.-L.; Chang, C. C. Y.; Urano, Y., Acyl-coenzyme A:cholesterol acyltransferases. Am. J. Physiol. Endocrinol. Metab. 2009, 297, E1-E9. 63.Leon, C.; Hill, J. S.; Wasan, K. M., Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharm. Res. 2005, 22, 1578-1588. 64.Zhang, J.; Kelley, K. L.; Marshall, S. M.; Davis, M. A.; Wilson, M. D.; Sawyer, J. K.; Farese, R. V., Jr.; Brown, J. M.; Rudel, L. L., Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood. J. Lipid Res. 2012, 53, 1144-1152. 65.Jiao, R.; Guan, L.; Yang, N.; Peng, C.; Liang, Y.; Ma, K. Y.; Huang, Y.; Chen, Z. Y., Frequent cholesterol intake up-regulates intestinal NPC1L1, ACAT2, and MTP. J. Agric. Food Chem. 2010, 58, 5851-5857. 66.Rudel, L. L.; Lee, R. G.; Parini, P., ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1112-1118. 67.Wetterau, J. R.; Combs, K. A.; Spinner, S. N.; Joiner, B. J., Protein disulfide isomerase is a component of the microsomal triglyceride transfer protein complex. J. Biol. Chem. 1990, 265, 9800-9807. 68.Hussain, M. M.; Rava, P.; Walsh, M.; Rana, M.; Iqbal, J., Multiple functions of microsomal triglyceride transfer protein. Nutr. Metab. (Lond.) 2012, 9, 14. 69.Vuorio, A.; Tikkanen, M. J.; Kovanen, P. T., Inhibition of hepatic microsomal triglyceride transfer protein - a novel therapeutic option for treatment of homozygous familial hypercholesterolemia. Vasc Health Risk Manag 2014, 10, 263-270. 70.Letteron, P.; Sutton, A.; Mansouri, A.; Fromenty, B.; Pessayre, D., Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 2003, 38, 133-140. 71.Desvergne, B.; Wahli, W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 1999, 20, 649-688. 72.Corton, J. C.; Anderson, S. P.; Stauber, A., Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 491-518. 73.Staels, B.; Fruchart, J. C., Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 2005, 54, 2460-2470. 74.Hsu, W. H.; Chen, T. H.; Lee, B. H.; Hsu, Y. W.; Pan, T. M., Monascin and ankaflavin act as natural AMPK activators with PPARalpha agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Food Chem. Toxicol. 2014, 64, 94-103. 75.Suk, F.-M.; Lin, S.-Y.; Chen, C.-H.; Yen, S.-J.; Su, C.-H.; Liu, D.-Z.; Hou, W.-C.; Hung, L.-F.; Lin, P.-J.; Liang, Y.-C., Taiwanofungus camphoratus activates peroxisome proliferator-activated receptors and induces hypotriglyceride in hypercholesterolemic rats. Biosci. Biotechnol. Biochem. 2014, 72, 1704-1713. 76.Smith, W. L.; Langenbach, R., Why there are two cyclooxygenase isozymes. J. Clin. Invest. 2001, 107, 1491-1495. 77.Suleyman, H.; Demircan, B.; Karagoz, Y., Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol. Rep. 2007, 59, 247-258. 78.Cipollone, F.; Cicolini, G.; Bucci, M., Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives. Pharmacol. Ther. 2008, 118, 161-180. 79.Gerke, V.; Moss, S. E., Annexins: from structure to function. Physiol. Rev. 2002, 82, 331-371. 80.Park, J. E.; Lee, D. H.; Lee, J. A.; Park, S. G.; Kim, N. S.; Park, B. C.; Cho, S., Annexin A3 is a potential angiogenic mediator. Biochem. Biophys. Res. Commun. 2005, 337, 1283-1287. 81.Watanabe, T.; Ito, Y.; Sato, A.; Hosono, T.; Niimi, S.; Ariga, T.; Seki, T., Annexin A3 as a negative regulator of adipocyte differentiation. J. Biochem. 2012, 152, 355-363. 82.Wu, N.; Liu, S.; Guo, C.; Hou, Z.; Sun, M. Z., The role of annexin A3 playing in cancers. Clin. Transl. Oncol. 2013, 15, 106-110. 83.Harashima, M.; Harada, K.; Ito, Y.; Hyuga, M.; Seki, T.; Ariga, T.; Yamaguchi, T.; Niimi, S., Annexin A3 expression increases in hepatocytes and is regulated by hepatocyte growth factor in rat liver regeneration. J. Biochem. 2008, 143, 537-545. 84.Spady, D. K.; Dietschy, J. M., Sterol synthesis in vivo in 18 tissues of the squirrel monkey, guinea pig, rabbit, hamster, and rat. J. Lipid Res. 1983, 24, 303-315. 85.Spady, D. K.; Bilheimer, D. W.; Dietschy, J. M., Rates of receptor-dependent and -independent low density lipoprotein uptake in the hamster. Proc. Natl. Acad. Sci. U. S. A. 1983, 80, 3499-3503. 86.Spady, D. K.; Dietschy, J. M., Rates of cholesterol synthesis and low-density lipoprotein uptake in the adrenal glands of the rat, hamster and rabbit in vivo. Biochim. Biophys. Acta 1985, 836, 167-175. 87.Arbeeny, C. M.; Meyers, D. S.; Bergquist, K. E.; Gregg, R. E., Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J. Lipid Res. 1992, 33, 843-851. 88.Bishop, R. W., Structure of the hamster low density lipoprotein receptor gene. J. Lipid Res. 1992, 33, 549-557. 89.Nistor, A.; Bulla, A.; Filip, D. A.; Radu, A., The hyperlipidemic hamster as a model of experimental atherosclerosis. Atherosclerosis 1987, 68, 159-173. 90.Bravo, E.; Cantafora, A.; Calcabrini, A.; Ortu, G., Why prefer the golden Syrian hamster (Mesocricetus auratus) to the Wistar rat in experimental studies on plasma lipoprotein metabolism? Comp. Biochem. Physiol., B: Comp. Biochem. 1994, 107, 347-355. 91.Zhang, Z.; Wang, H.; Jiao, R.; Peng, C.; Wong, Y. M.; Yeung, V. S.; Huang, Y.; Chen, Z. Y., Choosing hamsters but not rats as a model for studying plasma cholesterol-lowering activity of functional foods. Mol. Nutr. Food Res. 2009, 53, 921-930. 92.Moghadasian, M. H.; Frohlich, J. J.; Scudamore, C. H., Specificity of the commonly used enzymatic assay for plasma cholesterol determination. J. Clin. Pathol. 2002, 55, 859-861. 93.Foxall, T. L.; Shwaery, G. T.; Stucchi, A. F.; Nicolosi, R. J.; Wong, S. S., Dose-related effects of doxazosin on plasma lipids and aortic fatty streak formation in the hypercholesterolemic hamster model. Am. J. Pathol. 1992, 140, 1357-1363. 94.Chen, T. I.; Chen, C. C.; Lin, T. W.; Tsai, Y. T.; Nam, M. K., A 90-day subchronic toxicological assessment of Antrodia cinnamomea in Sprague-Dawley rats. Food Chem. Toxicol. 2011, 49, 429-433. 95.Bucolo, G.; David, H., Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 1973, 19, 476-482. 96.Friedewald, W. T.; Levy, R. I.; Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502. 97.Folch, J.; Lees, M.; Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509. 98.Carlson, S. E.; Goldfarb, S., A sensitive enzymatic method for determination of free and esterified tissue cholesterol. Clin. Chim. Acta 1977, 79, 575-582. 99.Gallagher, S.; Winston, S. E.; Fuller, S. A.; Hurrell, J. G., Immunoblotting and immunodetection. Curr. Protoc. Mol. Biol. 2004, 10.8, 1-24 100.Ohkawa, H.; Ohishi, N.; Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358. 101.Grundy, S. M.; Ahrens, E. H., Jr.; Miettinen, T. A., Quantitative isolation and gas--liquid chromatographic analysis of total fecal bile acids. J. Lipid Res. 1965, 6, 397-410. 102.Vasu, V. T.; Modi, H.; Thaikoottathil, J. V.; Gupta, S., Hypolipidaemic and antioxidant effect of Enicostemma littorale Blume aqueous extract in cholesterol fed rats. J. Ethnopharmacol. 2005, 101, 277-282. 103.Lin, Y. L.; Chang, Y. Y.; Yang, D. J.; Tzang, B. S.; Chen, Y. C., Beneficial effects of noni (Morinda citrifolia L.) juice on livers of high-fat dietary hamsters. Food Chem. 2013, 140, 31-38. 104.Wu, C. C.; Lin, S. Y.; Chen, C. T.; Chang, Y. P.; Huang, Y. S.; Lii, C. K.; Yu, C. C.; Hsieh, S. L.; Chung, J. G., Differential blood lipid-lowering effects of alkylsulfonated chitosan of different molecular weights in Syrian hamsters in vivo. Mol. Med. Rep. 2012, 5, 688-694. 105.Nagao, K.; Inoue, N.; Inafuku, M.; Shirouchi, B.; Morooka, T.; Nomura, S.; Nagamori, N.; Yanagita, T., Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice. J. Nutr. Biochem. 2010, 21, 418-423. 106.Chou, M.-C.; Chang, R.; Hung, Y.-H.; Chen, Y.-C.; Chiu, C.-H., Antrodia camphorata ameliorates high-fat-diet induced hepatic steatosis via improving lipid metabolism and antioxidative status. J. Funct. Foods 2013, 5, 1317-1325. 107.Liu, C. H.; Huang, M. T.; Huang, P. C., Sources of triacylglycerol accumulation in livers of rats fed a cholesterol-supplemented diet. Lipids 1995, 30, 527-531. 108.Guo, F.; Huang, C.; Liao, X.; Wang, Y.; He, Y.; Feng, R.; Li, Y.; Sun, C., Beneficial effects of mangiferin on hyperlipidemia in high-fat-fed hamsters. Mol. Nutr. Food Res. 2011, 55, 1809-1818. 109.Dai, F. J.; Hsu, W. H.; Huang, J. J.; Wu, S. C., Effect of pigeon pea (Cajanus cajan L.) on high-fat diet-induced hypercholesterolemia in hamsters. Food Chem. Toxicol. 2013, 53, 384-391. 110.Chien, Y. L.; Wu, L. Y.; Lee, T. C.; Hwang, L. S., Cholesterol-lowering effect of phytosterol-containing lactic-fermented milk powder in hamsters. Food Chem. 2010, 119, 1121-1126. 111.Huang, H.; Xie, Z.; Boue, S. M.; Bhatnagar, D.; Yokoyama, W.; Yu, L. L.; Wang, T. T., Cholesterol-lowering activity of soy-derived glyceollins in the golden Syrian hamster model. J. Agric. Food Chem. 2013, 61, 5772-5782. 112.Connolly, B. A.; O'Connell, D. P.; Lamon-Fava, S.; LeBlanc, D. F.; Kuang, Y. L.; Schaefer, E. J.; Coppage, A. L.; Benedict, C. R.; Kiritsy, C. P.; Bachovchin, W. W., The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans. Metabolism 2013, 62, 1840-1849. 113.van Heek, M.; Austin, T. M.; Farley, C.; Cook, J. A.; Tetzloff, G. G.; Davis, H. R., Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes 2001, 50, 1330-1335. 114.Chen, Z.-Y.; Jiao, R.; Ma, K. Y., Cholesterol-lowering nutraceuticals and functional foods. J. Agric. Food Chem. 2008, 56, 8761-8773. 115.Chen, Z.-Y.; Ma, K. Y.; Liang, Y.; Peng, C.; Zuo, Y., Role and classification of cholesterol-lowering functional foods. J. Funct. Foods 2011, 3, 61-69. 116.Plat, J.; Mensink, R. P., Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am. J. Cardiol. 2005, 96, 15d-22d. 117.AbuMweis, S. S.; Jones, P. J., Cholesterol-lowering effect of plant sterols. Curr. Atheroscler. Rep. 2008, 10, 467-472. 118.Lam, C. K.; Chen, J.; Cao, Y.; Yang, L.; Wong, Y. M.; Yeung, S. Y.; Yao, X.; Huang, Y.; Chen, Z. Y., Conjugated and non-conjugated octadecaenoic acids affect differently intestinal acyl coenzyme A: cholesterol acyltransferase activity. Atherosclerosis 2008, 198, 85-93. 119.Tzang, B.-S.; Yang, S.-F.; Fu, S.-G.; Yang, H.-C.; Sun, H.-L.; Chen, Y.-C., Effects of dietary flaxseed oil on cholesterol metabolism of hamsters. Food Chem. 2009, 114, 1450-1455. 120.Guo, H. X.; Liu, D. H.; Ma, Y.; Liu, J. F.; Wang, Y.; Du, Z. Y.; Wang, X.; Shen, J. K.; Peng, H. L., Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacol. Sin. 2009, 30, 1505-12. 121.Lee, H. I.; Yun, K. W.; Seo, K. I.; Kim, M. J.; Lee, M. K., Scopoletin prevents alcohol-induced hepatic lipid accumulation by modulating the AMPK-SREBP pathway in diet-induced obese mice. Metabolism 2014, 63, 593-601. 122.Choi, W. H.; Gwon, S. Y.; Ahn, J.; Jung, C. H.; Ha, T. Y., Cooked rice prevents hyperlipidemia in hamsters fed a high-fat/cholesterol diet by the regulation of the expression of hepatic genes involved in lipid metabolism. Nutr. Res. 2013, 33, 572-579. 123.Hsu, C.-L.; Chang, Y.-Y.; Chiu, C.-H.; Yang, K.-T.; Wang, Y.; Fu, S.-G.; Chen, Y.-C., Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters. Food Chem. 2011, 127, 1146-1152. 124.Chen, I. S.; Chang, Y. Y.; Hsu, C. L.; Lin, H. W.; Chang, M. H.; Chen, J. W.; Chen, S. S.; Chen, Y. C., Alleviative effects of deep-seawater drinking water on hepatic lipid accumulation and oxidation induced by a high-fat diet. J. Chin. Med. Assoc. 2013, 76, 95-101. 125.Peng, C. H.; Liu, L. K.; Chuang, C. M.; Chyau, C. C.; Huang, C. N.; Wang, C. J., Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis. J. Agric. Food Chem. 2011, 59, 2663-2671. 126.Hsieh, Y. L.; Yeh, Y. H.; Lee, Y. T.; Hsieh, C. H., Ameliorative effect of Pracparatum mungo extract on high cholesterol diets in hamsters. Food Funct. 2014, 5, 149-157. 127.Ito, Y.; Watanabe, T.; Nagatomo, S.; Seki, T.; Niimi, S.; Ariga, T., Annexin A3-expressing cellular phenotypes emerge from necrotic lesion in the pericentral area in 2-acetylaminofluoren/carbon tetrachloride-treated rat livers. Biosci. Biotechnol. Biochem. 2007, 71, 3082-9.126.
|